Descriptive epidemiology of Down's syndrome in Estonia

Paediatric and Perinatal Epidemiology

Volumn 20, Issue 6, 2006, Pages 512-519

  Reimand, Tiia ^a,b   Õunap, Katrin ^b   Zordania, Riina ^c   Ilus, Tiiu ^b   Uibo, Oivi ^a,d   Sitska, Mari ^b   Talvik, Tiina ^a,d  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c Tallinn's Children Hospital   (Estonia)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Down's syndrome; Livebirth prevalence; Prenatal screening; Time trend

Indexed keywords

ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DOWN SYNDROME; ESTONIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL SERUM; MOSAICISM; POPULATION RESEARCH; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; SECOND TRIMESTER PREGNANCY; SEX RATIO; TRISOMY;

ADULT; DOWN SYNDROME; ESTONIA; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 33750078961     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2006.00758.x     Document Type: Article

References (46)

1. Rosch C, Steinbicker V, Kropf S. Down's syndrome: the effects of prenatal diagnosis and demographic factors in a region of eastern part of Germany. European Journal of Epidemiology 2000; 16:627-632.
2. Leonard S, Bower C, Petterson B, Leonard H. Survival of infants born with Down's syndrome: 1980-96. Paediatric and Perinatal Epidemiology 2000; 14:163-171.
3. Hoshi N, Hattori R, Hanatani K, Okuyama K, Yamada H, Kishida T, et al. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997. American Journal of Medical Genetics 1999; 84:340-345.
4. Lai FM, Woo BH, Tan KH, Huang J, Lee ST, Yan TB, et al. Birth prevalence of Down syndrome in Singapore from 1993 to 1998. Singapore Medical Journal 2002; 43:70-76.
5. Raymond GV. Abnormal mental development. In: Emery and Rimoin's Principle and Practice of Medical Genetics. Editors: Rimoin DL, Connor JL, Pyeritz RE, Korf BR. London: Churchill Livingstone, 2002; pp. 1046-1065.
6. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359:1019-1025.
7. Baird PA, Sadovnick AD. Life tables for Down syndrome. Human Genetics 1989; 82:291-292.
8. Binkert F, Mutter M, Schinzel A. Impact of prenatal diagnosis on the prevalence of live births with Down syndrome in the eastern half of Switzerland 1980-1996. Swiss Medical Weekly 2002; 132:478-484.
9. Jones KL. Chromosomal abnormality syndromes. Down syndrome. In: Smith's Recognizable Patterns of Human Malformation. Philadelphia, PA: W.B. Saunders Company, 1997; pp. 8-10.
10. Ferguson-Smith M, Yates JRW. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenatal Diagnosis 1984; 4:5-44.
11. Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Human Genetics 1985; 70:11-17.
12. Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic Disorders and the Fetus. Editor: Milunsky A. Baltimore, MD: The Johns Hopkins University Press, 1998; pp. 179-248.
13. Resta GR. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. American Journal of Medical Genetics 2005; 133:31-36.
14. Milunsky A. Multianalyte maternal serum screening for chromosomal defects. In: Genetic Disorders and the Fetus. Editor: Milunsky A. Baltimore, MD: The Johns Hopkins University Press, 1998; p. 702.
15. Statistical Oficce of Estonia. Available at: http://www.stat.ee/index.aw? set_lang_id=2 [last accessed March 2005].
16. ISCN. An International System for Human Cytogenetic Nomenclature. Editor: Mitelman F. Basel: S. Karger, 1995.
17. Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenatal Diagnosis., 1999; 19:142-145.
18. Wright DE, Bray I. Estimating birth prevalence of Down's syndrome. Journal of Epidemiology and Biostatistics 2000; 5:89-98.
19. Bray I, Wright DE, Davies C, Hook EB. Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenatal Diagnosis 1998; 18:9-20.
20. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2005. ISBN 3-900051-07-0. Available at: http://www.R-project.org
21. Reimand T, Uibo O, Zordania R, Palmiste V, Ounap K, Talvik T. Parents' satisfaction with medical and social assistance provided to children with Down syndrome: experience in Estonia. Community Genetics 2003; 6:166-170.
22. Heuterman JSJ, de Walle HEK, Poortvliet MC, Bouman K, Cornel MC. Age at postnatal diagnosis of Down syndrome in the Northern Netherlands for the period 1981-2000. Community Genetics 2004; 7:55-59.
23. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Coffinet F. A population-based evaluation of the impact of antenatal screening for Down syndrome in France, 1981-2000. BJOG 2004; 111:485-490.
24. Verlodes A, Gillerot Y, Van Maldergem L, Schoos R, Herens C, Jamar M, et al. Major decrease in the incidence of trisomy 21 at birth in south Belgium: mass impact of triple test? European Journal of Human Genetics 2001; 9:1-4.
25. Jou HJ, Kuo YS, Hsu JJ, Shyu MK, Hsieh TT, Hsieh FJ. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening. Prenatal Diagnosis 2005; 25:665-670.
26. Bell R, Rankin J, Donaldson LJ. Down's syndrome: occurrence and outcome in the north of England, 1985-99. Paediatric and Perinatal Epidemiology 2003; 17:33-39.
27. Tolmie JL. Down syndrome and other autosomal trisomies. In: Emery and Rimoin's Principle and Practice of Medical Genetics, 4th edn. Editors: Rimoin DL, Connor JL, Pyeritz RE, Korf BR. London: Churchill Livingstone, 2002; pp. 1129-1152.
28. Huether CA, Martin RL, Stoppelman SM, D'Souza S, Bishop JK, Torfs CP, et al. Sex ratios in fetuses and liveborn infants with autosomal aneuploidy. American Journal of Medical Genetics 1996; 63:492-500.
29. Carothers AD, Castilla EE, Dutra MG, Hook EB. Search for ethnic, geographic, and other factors in the epidemiology of Down syndrome in South America: analysis of data from the ECLAMC project, 1967-1997. American Journal of Medical Genetics 2001; 103:149-156.
30. Zahed L, Megarbane A. A cytogenetic register of Down syndrome in Lebanon. Community Genetics 1998; 1:84-89.
31. Kovaleva NV. Sex ratio in Down syndome. Tsitologiia i Genetika 2002; 6:54-61. (in Russian).
32. Mutton D, Roy GI, Alberman E. Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989-97. British Medical Journal 1998; 317:922-923.
33. Saltvedt S, Almstrom H, Kublickas M, Valentin L, Botting R, Bui TH, et al. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39 572 pregnancies. Ultrasound in Obstetrics and Gynecology 2005; 25:537-545.
34. Sitska M, Kuuse K, Ilisson P, Ilus T, Tammur P, Reimand T, et al. Down's syndrome screening in Estonia. Eesti Arst 2003; 3:192-197. (in Estonian).
35. Sitska M, Ilisson P, Kuuse K, Ilus T, Tammur P, Reimand T, et al. Prenatal diagnostics in Estonia from 1990-2003. European Journal of Human Genetics 2005; 13:177, A-0452.
36. Olsen CL, Cross PK, Gensburg LJ, Hughes JP. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenatal Diagnosis 1996; 16:991-1102.
37. Chen H. Available at: http://www.emedicine.com/ped/topic615.htm [last accessed January 2006].
38. Mikkelsen M. Down syndrome: cytogenetical epidemiology. Hereditas 1977; 86:45-50.
39. Schinzel A. Chromosome 21. Trisomy and tetrasomy. In: Catalogue of Unbalanced Chromosome Aberrations in Man. Berlin: Walter de Gruyter, 2001; pp. 823-836.
40. Ahmed I, Ghafoor T, Samore NA, Ghattha MN. Down syndrome: clinical and cytogenetic analysis. Journal of the College of Physicians and Surgeons - Pakistan 2005; 15:426-429.
41. Mokhtar MM, Abd el-Aziz AM, Nazmy NA, Mahrous HS. Cytogenetic profile of Down syndrome in Alexandria, Egypt. Eastern Mediterranean Health Journal 2003; 9:37-44.
42. Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. Journal of Medical Genetics 1996; 33:387-394.
43. Thomas IM, Rajangam S, Hegde S. Cytogenetic investigations in Down syndrome patients and their parents. Indian Journal of Medical Research 1992; 96:366-371.
44. Kava MP, Tullu MS, Muranjan MN, Girisha KM. Down syndrome: clinical profile from India. Archives of Medical Research 2004; 35:31-34.
45. Kim SS, Jung SC, Kim HJ, Moon HR, Lee JS. Chromosome abnormalities in a referred population for suspected chromosomal aberrations: a report of 4117 cases. Journal of Korean Medical Science 1999; 14:373-376.
46. Pulliam LH, Huether CA. Translocation Down syndrome in Ohio 1970-1981: epidemiological and cytogenetic factors and mutation rate estimates. American Journal of Human Genetics 1986; 39:361-370.